(Reuters) -UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung condition, marking another win for the drugmaker's ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Finds Few Reasons To Sell. In this article, we are ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...

Mere months after announcing a partnership to develop digital support tools for cancer patients, Huma Therapeutics and Merck KGaA have launched their first app in the UK. The new app is directed ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

as investors cheered robust earnings from the likes of UK's Experian and Germany's Commerzbank, while rate-sensitive stocks got a boost after a softer-than-expected U.S. inflation print. Merck ...